4.3 Article

Therapeutic potential of PPARα agonist in ligature-induced experimental periodontitis

期刊

JOURNAL OF APPLIED ORAL SCIENCE
卷 30, 期 -, 页码 -

出版社

UNIV SAO PAULO FAC ODONTOLOGIA BAURU
DOI: 10.1590/1678-7757-2021-0648

关键词

Periodontitis; Fenofibrate; Inflammation; Bone loss

资金

  1. NIH NIDCR [R03DE030209-01, R01DE025255-06A1]

向作者/读者索取更多资源

The study demonstrates that PPARα agonist fenofibrate can effectively inhibit inflammatory responses and reduce bone loss in periodontitis. This anti-inflammatory treatment shows promising potential in combating periodontal diseases.
Inflammation-related immune responses and bone metabolism lead to extensive tooth loss in periodontitis. Objective: This study aims to investigate the effect of peroxisome proliferator-activated receptor (PPAR) alpha agonist anti-inflammatory treatment in vitro and in ligature-induced experimental periodontitis in vivo. Methodology: Splenocytes were isolated from C57BL/6J mice and cultured for 48 hours under the following conditions: control, P. gingivalis lipopolysaccharide (LPS) (1 mu g/ml); experimental, LPS (1 mu g/ml) + PPAR alpha agonist (fenofibrate) at 1, 10, 50, 100 mu M. MRNA and secreted protein levels of TNF-alpha expression were detected by RT-qPCR and ELISA, respectively. Silk ligatures (7-0) were tied around maxillary second molars of C57BL/6J mice for two weeks. Optimized doses of fenofibrate (50 mu M) and vehicle control were injected into the contralateral side of the palatal gingiva on days three, six, and nine. At day 14, bone resorption, osteoclastogenesis, and gingival mRNA expression levels of TNF-alpha, IL-1 beta, IL-6, and RANKL/OPG were measured by micro-computed tomography, Tartrate-resistant acid phosphatase (TRAP) staining, and Real-time quantitative PCR, respectively. Results: TNF-alpha expression in cultured spleen cells were significantly increased in the presence of LPS, when compared with the control group, and significantly reduced by fenofibrate treatment in a dose-dependent manner from 1-100 mu M (p<0.05). Gingival mRNA levels of TNF-alpha, IL-1 beta, IL-6, and the ratio of RANKL/OPG, were significantly decreased after injection of fenofibrate, when compared to the control side (p<0.05). Periodontal bone loss and TRAP positive cell formation were significantly decreased on the side with an injection of fenofibrate, as compared to the control side (p<0.05). Conclusions: An anti-inflammatory treatment, PPAR alpha agonist, inhibited inflammation and periodontal bone loss in ligature-induced experimental periodontitis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据